← back to search

Srinivas Murali

Drexel University · US
Area of research
Pulmonary and Respiratory Medicine · Biomedical Engineering
Research interest
Research focused on Transthyretin and Amyloidosis, with related work in Pulmonary hypertension, Statement (logic), Human genetics. Notable publications include 'Genotype and Phenotype of Transthyretin Cardiac Amyloidosis', 'World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council...', and 'Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update'.
h-index
citations
966
works
6
NIH funding
primary concept
email

Recent publications

Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay
Amyloid 2023cited by 14position: middledoi
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Orphanet Journal of Rare Diseases 2022cited by 88position: middledoi
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Cardiology and Therapy 2022cited by 45position: middledoi
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
JACC CardioOncology 2021cited by 60position: middledoi
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
Journal of the American College of Cardiology 2016cited by 527position: middledoi
World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation
The Journal of Heart and Lung Transplantation 2012cited by 232position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Angela Dispenzieri · Mayo Clinic1 papers (2016–2016) · 1 papers (2016–2016)D. Eric Steidley · WinnMed1 papers (2016–2016)Sanjiv J. Shah · Akron General Medical Center1 papers (2016–2016)Ronald Witteles · Alnylam Pharmaceuticals (United States)1 papers (2016–2016)Claudio Rapezzi · Fondazione Toscana Gabriele Monasterio1 papers (2016–2016)Márcia Waddington‐Cruz · Universidade Federal do Rio de Janeiro1 papers (2016–2016)Hector Ventura · RWTH Aachen University1 papers (2016–2016)James C. Fang · University of Utah1 papers (2012–2012)Mazen Hanna · Cleveland Clinic1 papers (2016–2016)Rajiv Mundayat · Pfizer (United States)1 papers (2016–2016)Gregory D. Lewis · Florida College1 papers (2012–2012)Barry A. Borlaug · Cleveland Clinic1 papers (2012–2012)Mardi Gomberg‐Maitland · German Center for Lung Research1 papers (2012–2012)J. Eduardo Rame · Thomas Jefferson University1 papers (2012–2012)Violaine Planté‐Bordeneuve · Inserm1 papers (2016–2016)Dana McGlothlin · Kaiser Permanente San Francisco Medical Center1 papers (2012–2012)Evelyn M. Horn · Cornell University1 papers (2012–2012)Daniel J. Lenihan · Society of Surgical Oncology1 papers (2016–2016)Mathew S. Maurer · Columbia University Irving Medical Center1 papers (2016–2016)